{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:10:28Z","timestamp":1775167828426,"version":"3.50.1"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T00:00:00Z","timestamp":1323129600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028250","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T21:57:49Z","timestamp":1323208669000},"page":"e28250","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":81,"title":["Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours"],"prefix":"10.1371","volume":"6","author":[{"given":"Ashley H.","family":"Birch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanna L.","family":"Arcand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen K.","family":"Oros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurosh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Kevin","family":"Watters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia M.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia N.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/cncr.11345","article-title":"Pathology and classification of ovarian tumors.","volume":"97","author":"VW Chen","year":"2003","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/gyno.2002.6711","article-title":"Long-term survival and patterns of care in women with ovarian tumors of low malignant potential.","volume":"86","author":"CL Trimble","year":"2002","journal-title":"Gynecol Oncol"},{"key":"ref3","first-page":"3","article-title":"Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.","volume":"99","author":"MA Crispens","year":"2002","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.","volume":"16","author":"R Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2007.11.013","article-title":"Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum.","volume":"108","author":"KM Schmeler","year":"2008","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11912-001-0039-y","article-title":"Genetic factors in ovarian carcinoma.","volume":"3","author":"AJ Li","year":"2001","journal-title":"Curr Oncol Rep"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2006.04.010","article-title":"Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.","volume":"170","author":"K Helou","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"ref8","first-page":"6172","article-title":"Genetic analysis of benign, low-grade, and high-grade ovarian tumors.","volume":"55","author":"H Iwabuchi","year":"1995","journal-title":"Cancer Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/1097-0142(20010201)91:3<534::AID-CNCR1031>3.0.CO;2-T","article-title":"Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation.","volume":"91","author":"M Kiechle","year":"2001","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/0008-5472.CAN-08-3913","article-title":"Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas.","volume":"69","author":"KT Kuo","year":"2009","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/hupa.2002.30212","article-title":"Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas.","volume":"33","author":"A Staebler","year":"2002","journal-title":"Hum Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.","volume":"29","author":"G Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0301-2115(98)00217-6","article-title":"Genetic alterations in ovarian borderline tumours and ovarian carcinomas.","volume":"82","author":"M Schuyer","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/jnci\/95.6.484","article-title":"Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.","volume":"95","author":"G Singer","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/1097-0142(19920701)70:1<152::AID-CNCR2820700125>3.0.CO;2-6","article-title":"Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases.","volume":"70","author":"M de Nictolis","year":"1992","journal-title":"Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biopha.2003.11.002","article-title":"The use of cytogenetics in understanding ovarian cancer.","volume":"58","author":"M Bernardini","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"ref17","first-page":"2765","article-title":"Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.","volume":"57","author":"F Mertens","year":"1997","journal-title":"Cancer Res"},{"key":"ref18","first-page":"4662","article-title":"Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.","volume":"59","author":"P Fullwood","year":"1999","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1038\/sj.onc.1202152","article-title":"Mapping of chromosome 3p deletions in human epithelial ovarian tumors.","volume":"17","author":"H Lounis","year":"1998","journal-title":"Oncogene"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/ijgc-00009577-200203000-00010","article-title":"Loss of heterozygosity at chromosome 3p in epithelial ovarian cancer in China.","volume":"12","author":"GL Zhang","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mc.10051","article-title":"Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.","volume":"34","author":"EN Manderson","year":"2002","journal-title":"Mol Carcinog"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.onc.1209821","article-title":"Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.","volume":"26","author":"NA Cody","year":"2007","journal-title":"Oncogene"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mc.20535","article-title":"Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer.","volume":"48","author":"NA Cody","year":"2009","journal-title":"Mol Carcinog"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/IGC.0b013e3181a3cd38","article-title":"Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.","volume":"19","author":"EN Manderson","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mc.20361","article-title":"Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.","volume":"47","author":"AH Birch","year":"2008","journal-title":"Mol Carcinog"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.molonc.2008.12.005","article-title":"Large-scale genomic analysis of ovarian carcinomas.","volume":"3","author":"KL Gorringe","year":"2009","journal-title":"Mol Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/1078-0432.CCR-07-0502","article-title":"High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.","volume":"13","author":"KL Gorringe","year":"2007","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1053\/hupa.2002.124913","article-title":"Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.","volume":"33","author":"S Hauptmann","year":"2002","journal-title":"Hum Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-4608(02)00603-9","article-title":"Genomic imbalances in ovarian borderline serous and mucinous tumors.","volume":"139","author":"J Hu","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cancergencyto.2006.01.009","article-title":"Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas.","volume":"167","author":"L Osterberg","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<307::AID-GCC1>3.0.CO;2-1","article-title":"Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization.","volume":"25","author":"NG Wolf","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ijc.2910470308","article-title":"Bilateral ovarian carcinoma: cytogenetic evidence of unicentric origin.","volume":"47","author":"T Pejovic","year":"1991","journal-title":"Int J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ajhg.2008.08.007","article-title":"Runs of homozygosity in European populations.","volume":"83","author":"R McQuillan","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddl436","article-title":"Genome-wide SNP assay reveals structural genomic variation, extended homozygosity and cell-line induced alterations in normal individuals.","volume":"16","author":"J Simon-Sanchez","year":"2007","journal-title":"Hum Mol Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2005.10.010","article-title":"Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.","volume":"241","author":"M Imura","year":"2006","journal-title":"Cancer Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ygyno.2004.06.018","article-title":"Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer.","volume":"94","author":"D Katsaros","year":"2004","journal-title":"Gynecol Oncol"},{"key":"ref37","article-title":"Frequency of mismatch repair deficiency in ovarian cancer: A systematic review.","author":"MA Murphy","year":"2010","journal-title":"Int J Cancer"},{"key":"ref38","first-page":"2150","article-title":"Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.","volume":"55","author":"DC Schultz","year":"1995","journal-title":"Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.10207","article-title":"Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21).","volume":"37","author":"A Charest","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e15640","DOI":"10.1371\/journal.pone.0015640","article-title":"Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.","volume":"6","author":"TL Gu","year":"2011","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/gyno.1998.5235","article-title":"Differences in p16 gene methylation and expression in benign and malignant ovarian tumors.","volume":"72","author":"LL McCluskey","year":"1999","journal-title":"Gynecol Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00428-005-0091-3","article-title":"Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.","volume":"448","author":"YL Choi","year":"2006","journal-title":"Virchows Arch"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1038\/sj.onc.1201372","article-title":"Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumours.","volume":"15","author":"WJ Roy Jr","year":"1997","journal-title":"Oncogene"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ijc.11107","article-title":"Genetic analysis of benign ovarian tumors.","volume":"105","author":"NA Thomas","year":"2003","journal-title":"Int J Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ajhg.2008.01.012","article-title":"SNP arrays in heterogeneous tissue: highly accurate collection of both germline and somatic genetic information from unpaired single tumor samples.","volume":"82","author":"G Assie","year":"2008","journal-title":"Am J Hum Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/gcc.20332","article-title":"Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.","volume":"45","author":"D Angeloni","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/hmg\/ddi493","article-title":"Extended tracts of homozygosity in outbred human populations.","volume":"15","author":"J Gibson","year":"2006","journal-title":"Hum Mol Genet"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/gepi.20344","article-title":"Genome-wide autozygosity mapping in human populations.","volume":"33","author":"S Wang","year":"2009","journal-title":"Genet Epidemiol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00439-010-0945-x","article-title":"Genomic and genealogical investigation of the French Canadian founder population structure.","volume":"129","author":"MH Roy-Gagnon","year":"2011","journal-title":"Hum Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"19942","DOI":"10.1073\/pnas.0710021104","article-title":"Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia.","volume":"104","author":"T Lencz","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-010-0920-6","article-title":"Regions of homozygosity and their impact on complex diseases and traits.","volume":"129","author":"CS Ku","year":"2011","journal-title":"Hum Genet"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-4608(96)00169-0","article-title":"Karyotypic characteristics of borderline malignant tumors of the ovary: trisomy 12, trisomy 7, and r(1) as nonrandom features.","volume":"92","author":"T Pejovic","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.2910480508","article-title":"Trisomy 12 and K-ras-2 amplification in human ovarian tumors.","volume":"48","author":"TL Yang-Feng","year":"1991","journal-title":"Int J Cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/1541-7786.MCR-08-0532","article-title":"Oncogenic activating mutations are associated with local copy gain.","volume":"7","author":"B Modrek","year":"2009","journal-title":"Mol Cancer Res"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JTO.0b013e31820594f0","article-title":"Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.","volume":"6","author":"H Sasaki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.","volume":"53","author":"C Almoguera","year":"1988","journal-title":"Cell"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrm2858","article-title":"Genomic instability\u2013an evolving hallmark of cancer.","volume":"11","author":"S Negrini","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer.","volume":"26","author":"CN Landen Jr","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.","volume":"65","author":"T Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1038\/sj.onc.1208214","article-title":"Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling.","volume":"24","author":"V Ouellet","year":"2005","journal-title":"Oncogene"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/hmg\/ddp011","article-title":"Copy number variants, diseases and gene expression.","volume":"18","author":"CN Henrichsen","year":"2009","journal-title":"Hum Mol Genet"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1073\/pnas.242741799","article-title":"Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma.","volume":"100","author":"A Charest","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1158\/0008-5472.CAN-06-1193","article-title":"ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2\/phosphatidylinositol 3-kinase\/mammalian target of rapamycin signaling axis to form glioblastoma in mice.","volume":"66","author":"A Charest","year":"2006","journal-title":"Cancer Res"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"bar018","DOI":"10.1093\/database\/bar018","article-title":"Data mining using the Catalogue of Somatic Mutations in Cancer BioMart.","volume":"2011","author":"R Shepherd","year":"2011","journal-title":"Database (Oxford)"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma.","volume":"474","year":"2011","journal-title":"Nature"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2407-8-152","article-title":"Characterization of three new serous epithelial ovarian cancer cell lines.","volume":"8","author":"V Ouellet","year":"2008","journal-title":"BMC Cancer"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1290\/1071-2690(2000)036<0357:COFNEO>2.0.CO;2","article-title":"Characterization of four novel epithelial ovarian cancer cell lines.","volume":"36","author":"DM Provencher","year":"2000","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/excr.1994.1346","article-title":"Primary cultures of normal and tumoral human ovarian epithelium: a powerful tool for basic molecular studies.","volume":"215","author":"H Lounis","year":"1994","journal-title":"Exp Cell Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"pdb prot5138","DOI":"10.1101\/pdb.prot5138","article-title":"DNA extraction from formalin-fixed, paraffin-embedded tissue.","volume":"2009","author":"W Tang","year":"2009","journal-title":"Cold Spring Harb Protoc"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.onc.1206219","article-title":"Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.","volume":"22","author":"N Presneau","year":"2003","journal-title":"Oncogene"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"D613","DOI":"10.1093\/nar\/gkp939","article-title":"The UCSC Genome Browser database: update 2010.","volume":"38","author":"B Rhead","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-007-9608-6","article-title":"Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families.","volume":"108","author":"SL Arcand","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1093\/nar\/22.15.2990","article-title":"High sensitivity mapping of methylated cytosines.","volume":"22","author":"SJ Clark","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jnci\/93.9.691","article-title":"Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.","volume":"93","author":"DG Burbee","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","article-title":"Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.","volume":"93","author":"JG Herman","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","article-title":"Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.","volume":"95","author":"JG Herman","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1093\/nar\/gkp493","article-title":"Integrated study of copy number states and genotype calls using high-density SNP arrays.","volume":"37","author":"W Sun","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mc.20096","article-title":"Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1\u2013q25.2.","volume":"43","author":"N Presneau","year":"2005","journal-title":"Mol Carcinog"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T01:01:12Z","timestamp":1742000472000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028250"}},"subtitle":[],"editor":[{"given":"John D.","family":"Minna","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,6]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028250","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,6]]}}}